U.S. Food and Drug Administration

The U.S. Food and Drug Administration on June 23 said it was ordering all products produced by Juul Labs off the market after finding the vaping giant had failed to address certain safety concerns.

The decision, which Juul said it would appeal, clears the way for rival brands to increase their share of the market it once dominated.

The Turkish Health Ministry's Science Board will look into whether the COVID-19 vaccine could be administered to children aged between 5 and 11 after the U.S. Food and Drug Administration's (FDA) Advisory Committee recommended the Pfizer/BioNTech jab for this age group.

Pfizer Inc and BioNTech SE have asked U.S. regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11, a group for whom no shot is currently allowed, Pfizer said on Oct. 7.

The U.S. Food and Drug Administration said on June 11 it had told Johnson & Johnson that millions of doses of Covid vaccine produced at a troubled plant can't be used because of possible contamination issues.

U.S. health authorities have recommended pausing the Johnson & Johnson COVID-19 shot over blood clot fears, with the company announcing it would delay its European rollout in a setback for global immunization efforts.

As Canadians, Britons and Americans begin getting immunized with a German-developed vaccine against coronavirus, pressure is building on the European Medicines Agency to approve the shot made by Pfizer Inc. and the German company BioNTech.

German officials have been especially vocal that they want it approved before Christmas. Here's a look at the EMA approval process:

The United States prepared to start its COVID-19 vaccination program on Dec. 14 as the nation's death toll edged towards 300,000, while Germany announced a partial lockdown over the holidays due to an explosion of cases.

A panel of outside advisers to the U.S. Food and Drug Administration on Thursday voted overwhelmingly to endorse emergency use of Pfizer's coronavirus vaccine, paving the way for the agency to authorize the shot for a nation that has lost more than 285,000 lives to COVID-19.

Britain's medicine regulator has advised that people with a history of significant allergies do not get Pfizer-BioNTech's COVID-19 vaccine after two people reported severe adverse reactions on the first day of rollout.

U.S. coronavirus cases crossed the 15 million mark on Tuesday as regulators moved a step closer to approving a COVID-19 vaccine and Britain started inoculating people, offering hope of slowing a pandemic that killed 15,000 Americans in the last week alone.